Compounded Semaglutide Injection

Compounded GLP-1. Weekly subcutaneous self-injection

GLP-1 receptor agonist that slows gastric emptying, dampens appetite signals, and improves glucose regulation.

Dosing: Set by your prescriber and adjusted over time based on how you respond.

Best for: Patients seeking proven semaglutide-based weight loss with a clinician-guided titration plan.

Key points

Contains semaglutide; not FDA-approved and not an approved generic of branded semaglutide products
Weekly injection, most patients self-administer at home
Compounded by a US 503A pharmacy when clinically appropriate
Includes ongoing HELiXVi clinician support

Prescription-only, requires licensed clinician review
Common side effects: nausea, constipation, reflux, fatigue during titration
Not for patients with a personal or family history of medullary thyroid carcinoma or MEN 2

Prescription treatment requires an online consultation with a licensed HELiXVi clinician. Individual results vary.

No clinic visit. Licensed US clinicians. Dispatched within 24 hours of your consultation and payment.